Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Navidea Biopharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +2 vs. Q4 2022
- Shares held
- 1.40M
- −230.6K (−14.1%) vs. Q4 2022
- Total value
- $364.4K
- +$25.1K (+7.4%) vs. Q4 2022
- New holders
- 4
- 3 more added
- Sold out
- 2
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 2 | $13 |
| Q4 2023 | 4 | $469 |
| Q3 2023 | 24 | $225.8K |
| Q2 2023 | 23 | $138.5K |
| Q1 2023 | 30 | $364.4K |
| Q4 2022 | 28 | $339.3K |
| Q3 2022 | 25 | $379.6K |
| Q2 2022 | 26 | $1.08M |
| Q1 2022 | 25 | $1.19M |
| Q4 2021 | 31 | $1.68M |
| Q3 2021 | 29 | $2.76M |
| Q2 2021 | 31 | $3.08M |
| Q1 2021 | 35 | $3.77M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Navidea Biopharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 286,638 | $74.5K | 0.00% | −381,102−57.1% | Reduced |
| Renaissance Technologies LLC | 238,133 | $62.0K | 0.00% | +172,800+264.5% | Added |
| Allred Capital Management, LLC | 164,738 | $42.8K | 0.02% | +54,300+49.2% | Added |
| Millennium Management LLC | 128,756 | $33.0K | 0.00% | +128,756 | New |
| BlackRock Inc. | 112,884 | $29.4K | 0.00% | −145−0.1% | Reduced |
| Geode Capital Management, LLC | 104,619 | $27.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 102,440 | $26.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 65,807 | $17.1K | 0.00% | −28,042−29.9% | Reduced |
| Northern Trust Corp | 39,414 | $10.2K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 28,026 | $7.29K | 0.00% | −133,224−82.6% | Reduced |
| Simplex Trading, LLC | 28,416 | $7.00K | 0.00% | −100−0.4% | Reduced |
| State Street Corp | 23,843 | $6.20K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 19,325 | $5.03K | 0.00% | −1,820−8.6% | Reduced |
| Wolverine Trading, LLC | 16,297 | $5.00K | 0.00% | −639−3.8% | Reduced |
| Virtu Financial LLC | 16,301 | $4.00K | 0.00% | −17,353−51.6% | Reduced |
| Pathstone Family Office, LLC | 10,043 | $2.61K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,911 | $2.00K | 0.00% | +11+0.1% | Added |
| Wells Fargo & Company | 5,471 | $1.42K | 0.00% | −1,829−25.1% | Reduced |
| Bank of America Corp | 1,179 | $307 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,000 | $260 | 0.00% | +1,000 | New |
| Sound Income Strategies, LLC | 599 | $156 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 350 | $91 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 266 | $69 | 0.00% | −31−10.4% | Reduced |
| Advisory Services Network, LLC | 250 | $65 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 100 | $26 | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 50 | $13 | 0.00% | 00.0% | Unchanged |
| Beacon Capital Management, LLC | 10 | $3 | 0.00% | 00.0% | Unchanged |
| Country Trust Bank | 7 | $2 | 0.00% | +7 | New |
| JPMorgan Chase & Co | 1,300 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |
| PDS Planning, Inc | 0 | $0 | 0.00% | −10,565−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,614−100.0% | Sold out |